CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway 期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 卷号: 19
作者:  Zhu, Zhongsheng;  Li, Linyu;  Zhang, Xiaorong
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 6
作者:  Jiang, Zefei;  Li, Wei;  Hu, Xichun;  Zhang, Qingyuan;  Sun, Tao
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation 期刊论文
MEDICAL SCIENCE MONITOR, 2019, 卷号: 25
作者:  Zhu, Zhongsheng;  Li, Jinyu;  Zhang, Xiaorong
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Toll-like receptor 9 inactivation ameliorates ox-LDL injured HUVEC activity in vitro 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 卷号: 11, 期号: 9
作者:  Zhu, Zhongsheng;  Li, Jinyu;  Kan, Lihong
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
TLR9  IRS869  ODN1826  HUVECs  ox-LDL  
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis 期刊论文
NATURE COMMUNICATIONS, 2017, 卷号: 8
作者:  Huang, Lihua;  Qing, Zhuye;  Wu, Jianfang;  Huang, Qinghai;  Han, Junhai
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China 期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 35
作者:  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li;  Feng, Jifeng
收藏  |  浏览/下载：64/0  |  提交时间：2019/12/05
National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2015, 卷号: 4, 期号: 5
作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/13
Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文
作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace